Jeffrey H. Cooper

2009 - BioMarin Pharmaceutical

In 2009, Jeffrey H. Cooper earned a total compensation of $1.1M as Senior Vice President, Chief Financial Officer at BioMarin Pharmaceutical, a 45% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$133,405
Option Awards$455,400
Salary$351,408
Stock Awards$115,120
Other$7,598
Total$1,062,931

Cooper received $455.4K in option awards, accounting for 43% of the total pay in 2009.

Cooper also received $133.4K in non-equity incentive plan, $351.4K in salary, $115.1K in stock awards and $7.6K in other compensation.

Rankings

In 2009, Jeffrey H. Cooper's compensation ranked 4,256th out of 9,885 executives tracked by ExecPay. In other words, Cooper earned more than 56.9% of executives.

ClassificationRankingPercentile
All
4,256
out of 9,885
57th
Division
Manufacturing
1,515
out of 3,690
59th
Major group
Chemicals And Allied Products
288
out of 866
67th
Industry group
Drugs
174
out of 638
73rd
Industry
Pharmaceutical Preparations
137
out of 446
69th
Source: SEC filing on March 23, 2012.

Cooper's colleagues

We found four more compensation records of executives who worked with Jeffrey H. Cooper at BioMarin Pharmaceutical in 2009.

2009

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

2009

Henry Fuchs

BioMarin Pharmaceutical

Chief Medical Officer

2009

Stephen Aselage

BioMarin Pharmaceutical

Executive Vice President & Chief Business Officer

2009

Robert Baffi

BioMarin Pharmaceutical

Executive Vice President, Technical Operations

You may also like